Applying the estimand framework to inflammatory bowel disease clinical trials (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(25)00004-4
Publication URI: http://dx.doi.org/10.1016/s2468-1253(25)00004-4
Type: Journal Article/Review
Parent Publication: The Lancet Gastroenterology & Hepatology